References
- Abdelsaid, M., et al., 2014. Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes. Life Sciences, 118(2), 263–267.
- Arbel-Ornath, M., et al., 2013. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer’s disease mouse models. Acta Neuropathologica, 126(3), 353–364.
- Bell, R.D., et al., 2007. Transport pathways for clearance of human Alzheimer’s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. Journal of Cerebral Blood Flow & Metabolism, 27(5), 909–918.
- Ben-Zvi, A., et al., 2014. MSFD2A is critical for the formation and function of the blood–brain barrier. Nature, 509(7501), 507.
- Bourgade, K., et al., 2015. β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1. Biogerontology, 16(1), 85–98.
- Burfeind, K.G., et al., 2017. The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer’s disease. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 3(3), 348–359.
- Deane, R., et al., 2009. Clearance of amyloid-beta peptide across the blood–brain barrier: implication for therapies in Alzheimer’s disease. CNS & Neurological Disorders - Drug Targets, 8(1), 16–30.
- Eimer, W.A., et al., 2018. Alzheimer’s disease-associated β-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron, 99(1), 56–63.e3.
- Fu, W., et al., 2018. Tongluo Xingnao effervescent tablet reverses memory deficit and reduces plaque load in APPswe/PS1dE9 mice. Experimental and Therapeutic Medicine, 15(4), 4005–4013.
- Gunn, C., et al., 2018. A systematic review of the next-day effects of heavy alcohol consumption on cognitive performance. Addiction, 113(12), 2182–2193.
- Iliff, J.J., et al., 2012. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Science Translational Medicine, 4(147), 147ra111.
- Kumar, D.K., et al., 2016. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Science Translational Medicine, 8(340), 340ra372.
- Lue, L.F., et al., 2017. Amyloid beta and tau as Alzheimer’s disease blood biomarkers: promise from new technologies. Neurology and Therapy, 6(S1), 25–36.
- Muneer, A., et al., 2012. The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(5), 1167–1177.
- Nutaitis, A.C., et al., 2019. Diet as a risk factor for cognitive decline in African Americans and Caucasians with a parental history of Alzheimer’s disease: a cross-sectional pilot study dietary patterns. The Journal of Prevention of Alzheimer’s Disease, 6(1), 50–55.
- Poznanski, P., et al., 2018. Ethanol consumption following mild traumatic brain injury is related to blood–brain barrier permeability. Addiction Biology. Available from: https://doi.org/10.1111/adb.12683
- Rubio-Araiz, A., et al., 2017. Disruption of blood–brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge-like drinking model. Addiction Biology, 22(4), 1103–1116.
- Scarmeas, N., et al., 2018. Nutrition and prevention of cognitive impairment. The Lancet Neurology, 17(11), 1006–1015.
- Schwarzinger, M., et al., 2018. Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. The Lancet Public Health, 3(3), e124–e132.
- Spear, L.P., 2018. Effects of adolescent alcohol consumption on the brain and behaviour. Nature Reviews Neuroscience, 19(4), 197–214.
- Venkataraman A., et al., 2016. Alcohol and Alzheimer’s disease-does alcohol dependence contribute to beta-amyloid deposition, neuroinflammation and neurodegeneration in Alzheimer’s disease? Alcohol & Alcoholism, 52(2), 151–158.
- Wei, X., et al., 2017. Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies. European Journal of Epidemiology, 32(1), 31–42.
- Xu, Z., et al., 2015. Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits. Molecular Neurodegeneration, 10(1), 58.
- Yang, Y.R., et al., 2017. Mfsd2a (major facilitator superfamily domain containing 2a) attenuates intracerebral hemorrhage–induced blood–brain barrier disruption by inhibiting vesicular transcytosis. Journal of the American Heart Association Cardiovascular Association, 6(7), e005811.